BCM Advisors’s Merck MRK Stock Holding History

BCM Advisors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-408	Closed	-$23K	–	69
2016 Q4	$23K	Buy	+408	New	+$23.9K	0.02%	58

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BCM Advisors's MRK Position: Q1 2017 in Review

BCM Advisors sold out of Merck (MRK) in Q1 2017, closing a stake of 408 shares — an estimated $23K sold.

BCM Advisors first reported a position in MRK in Q4 2016 and held it in 1 quarter. The position peaked at $23K in Q4 2016. 1,942 funds tracked by Wall St. Rank hold MRK as of Q1 2017.

BCM Advisors reported no remaining Merck position as of Q1 2017 after selling out during the quarter.
BCM Advisors sold 408 Merck shares in Q1 2017, an estimated $23K.
BCM Advisors first reported a position in Merck in Q4 2016 and held it in 1 quarter.
BCM Advisors's Merck position peaked at $23K in Q4 2016.
1,942 funds tracked by Wall St. Rank held Merck as of Q1 2017.

Based on BCM Advisors's 13F filing for Q1 2017, filed 12 May 2017.